Comment on Ozempic, other weight-loss drugs face backlash from companies, lawyers. What you need to know

Ozempic, other weight-loss drugs face backlash from companies, lawyers. What you need to know

The latest news in weight-loss drugs turned negative this week. What a difference a month makes in the never-boring world of weight-loss drugs. Last month—when the news was so bullish that semaglutides (or GLP-1s, as this class of drugs is known) such as Ozempic and Wegovy might also cure all addiction—Morgan Stanley analysts raised their estimate for the size of the anti-obesity market to $77 billion worldwide in 2030, up $23 billion from the previous forecast.Read Full Story

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News